Medicare Enrolled
Dr. George Soliman, M.D.
Pain Medicine · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Soliman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soliman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Soliman
Dr. George Soliman is a pain medicine in Fort Myers, FL, with 12 years in practice. Based on federal Medicare data, Dr. Soliman performed 48,029 Medicare services across 6,421 unique beneficiaries.
Between the years covered by Open Payments, Dr. Soliman received a total of $16,126 from 51 pharmaceutical and/or device companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soliman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 3% volume in FL$ $16,126 industry payments
Medicare Practice Summary
Medicare Utilization ↗48,029
Medicare services
Top 3% in FL for pain medicine
6,421
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,002 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) | 18,267 | $1 | $4 |
| Botox injection, per unit | 9,200 | $5 | $18 |
| Dexamethasone injection (steroid) | 6,185 | $0 | $1 |
| Contrast dye for imaging, lower concentration | 5,441 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,357 | $90 | $322 |
| Extended-release steroid injection (Zilretta) | 992 | $13 | $51 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 766 | $122 | $449 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 761 | $268 | $1,072 |
| Betamethasone steroid injection | 570 | $5 | $19 |
| Contrast dye for imaging (iodine-based) | 523 | $0 | $4 |
| Injection, ketorolac tromethamine, per 15 mg | 487 | $0 | $1 |
| Injection of substance into lower spine canal using imaging guidance | 265 | $210 | $769 |
| New patient office visit (45-59 min) | 228 | $123 | $480 |
| Injection of substance into middle or upper spine canal using imaging guidance | 215 | $209 | $776 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 175 | $206 | $784 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 167 | $108 | $405 |
| Injection of trigger points, 1-2 muscles | 156 | $44 | $161 |
| X-ray of lower and sacral spine, minimum of 4 views | 143 | $41 | $148 |
| Mri scan of lower spinal canal without contrast | 132 | $138 | $530 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 126 | $1 | $150 |
| Office visit, established patient (20-29 min) | 123 | $74 | $273 |
| Injection, cefazolin sodium, 500 mg | 122 | $1 | $3 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 107 | $285 | $795 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 100 | $520 | $1,927 |
| Joint injection, major joint | 86 | $62 | $272 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 85 | $218 | $840 |
| Ultrasonic guidance for needle placement | 84 | $48 | $225 |
| Injection of trigger points, 3 or more muscles | 83 | $49 | $170 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 83 | $112 | $420 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 65 | $84 | $322 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 65 | $159 | $606 |
| X-ray of upper spine, 6 or more views | 61 | $47 | $180 |
| Fluoroscopic guidance for needle placement | 53 | $94 | $320 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 45 | $63 | $227 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 43 | $221 | $614 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 42 | $123 | $439 |
| X-ray lower and sacral spine, minimum of 6 views | 40 | $42 | $184 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 39 | $369 | $1,379 |
| Destruction of nerve branches of knee using imaging guidance | 37 | $320 | $1,199 |
| New patient office visit, complex (60-74 min) | 35 | $176 | $632 |
| X-ray of middle spine, 2 views | 34 | $26 | $98 |
| Hip X-ray, 2-3 views | 34 | $37 | $127 |
| Mri scan of upper spinal canal without contrast | 33 | $139 | $535 |
| Injection of contrast for imaging of hip under anesthesia | 32 | $256 | $830 |
| Review by radiologist of hip joint image | 31 | $114 | $350 |
| Drug injection, under skin or into muscle | 31 | $12 | $46 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 29 | $195 | $702 |
| Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance | 28 | $4,732 | $19,325 |
| Shoulder X-ray, 2+ views | 27 | $30 | $97 |
| Office visit, established patient, complex (40-54 min) | 26 | $137 | $506 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 24 | $136 | $410 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 21 | $273 | $3,519 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | 21 | $133 | $506 |
| Mri scan of middle spinal canal without contrast | 21 | $143 | $563 |
| Treatment of broken lower spine bone with placement of stabilizing device | 20 | $4,710 | $19,249 |
| X-ray of knee, 4 or more views | 18 | $41 | $141 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 17 | $43 | $128 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $75 | $275 |
| Treatment of broken spine bone with stabilizing device, each additional segment | 13 | $2,432 | $10,572 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,126
Total received (2018-2024)
Avg $2,304/year across 7 years
Top 11% in FL for pain medicine
51
Companies
421
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,126 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,373
2023$7,295
2022$1,554
2021$1,033
2020$790
2019$2,367
2018$714
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$3,132
Abbott Laboratories
$2,055
Stryker Corporation
$1,900
Relievant Medsystems, Inc.
$1,412
Nevro Corp.
$1,064
ABBVIE INC.
$840
Amgen Inc.
$790
AbbVie Inc.
$769
Medtronic, Inc.
$581
Collegium Pharmaceutical, Inc.
$314
SCILEX PHARMACEUTICALS INC.
$304
BIONESS INC
$250
Allergan, Inc.
$208
PFIZER INC.
$199
Scilex Pharmaceuticals Inc.
$179
Spinal Simplicity, LLC
$170
Biohaven Pharmaceutical Holding Company Ltd.
$168
BioDelivery Sciences International, Inc.
$158
Stimwave Technologies Incorporated
$137
Flexion Therapeutics, Inc.
$127
MML US, Inc.
$120
Curonix LLC
$95
Vertos Medical, Inc.
$93
Daiichi Sankyo Inc.
$92
Radius Health, Inc.
$92
Teva Pharmaceuticals USA, Inc.
$86
Endo Pharmaceuticals Inc.
$68
Merz Pharmaceuticals, LLC
$62
Biohaven Pharmaceuticals, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$54
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$51
Allergan Inc.
$41
Sonex Health, Inc.
$33
Avanos Medical
$30
Lilly USA, LLC
$29
SPR Therapeutics, Inc
$29
Kaleo, Inc.
$29
FIDIA PHARMA USA INC.
$27
Forte Bio-Pharma LLC
$27
Saluda Medical Americas, Inc.
$26
DePuy Synthes Sales Inc.
$25
Novartis Pharmaceuticals Corporation
$24
Fidia Pharma USA Inc.
$24
Orthogenrx Inc.
$24
SI-BONE, INC.
$24
Horizon Therapeutics plc
$19
PAINTEQ LLC
$19
Pacira Therapeutics, Inc.
$19
Pacira Pharmaceuticals Incorporated
$18
ERMI LLC
$17
Currax Pharmaceuticals LLC
$13
Top 3 companies account for 43.9% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AUTOPLEX · Aimovig · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · CONTRAVE · EMGALITY · ETERNA · EVENITY · Evoke · Evzio · GENERAL VASCULAR INTERVENTION · GENERAL - PAIN MANAGEMENT · GenVisc 850 · General - Pain Management · HA MINUTEMAN G3-R · HYMOVIS · Hymovis · IFUSE IMPLANT · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN RF · Intracept · Iovera · LUCEMYRA · MONOVISC · Morphabond ER · NALOCET · NURTEC ODT · NuDyn · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PRODIGY · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prolia · QULIPTA · RELISTOR · ReActiv8 · SPINEJACK · SPRINT PNS System · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · StimRouter for pain · Superion Indirect Decompression System · TRIVISC SODIUM HYALURONATE · Turalio · Tymlos · UBRELVY · ULTRAGUIDECTR · VANTA ADAPTIVESTIM · VENOUS WALLSTENT · XIAFLEX · XTAMPZA · Xeomin · ZTLido · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $34 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
7
Per 100K population
0.9
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Soliman is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 11%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Soliman experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Soliman performed 18,267 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soliman receive payments from pharmaceutical companies?
Yes. Dr. Soliman received a total of $16,126 from 51 companies across 421 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soliman's costs compare to other pain medicines in Fort Myers?
Dr. Soliman's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soliman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Fort Myers
Browse pain medicines in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in FL
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in FL
Which FL pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology